Skip Navigation

A Phase II Study of Loxo-292 in Patients with Ret Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer LUNG-MAP Sub-Study

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04268550

Study #:
STUDY00145444

Start Date:
May 26, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04268550

View Complete Trial Details & Eligibility at ClinicalTrials.gov